RESEARCH PEPTIDE
PT-141
10mg
MELANOCORTIN RECEPTOR AGONIST
PT-141 (Bremelanotide) is a cyclic 7-amino-acid peptide and melanocortin receptor agonist. Extensively studied for its role in central nervous system signaling, neuromodulation, and behavioral research, it represents a significant compound in melanocortin pathway investigations.
View Research Information Center
MECHANISM OF ACTION
How PT-141 Works
PT-141 selectively activates melanocortin receptors, particularly MC4R and MC3R, influencing central nervous system pathways involved in neuromodulation and behavioral regulation.
Binds to MC4R and MC3R, influencing central signaling pathways.
Modulates neural pathways involved in behavior and motivation research.
Studied for its effects on neurotransmitter systems in the brain.
Investigated for its role in neural circuits and behavioral regulation.
May influence hypothalamic pathways involved in neuroendocrine function.
Studied for its potential to modulate neural activity and behavioral responses.
Research Applications
POTENTIAL BENEFITS
Key Benefits in Research Studies
Studied for its role in central nervous system regulation.
Investigated for effects on neural behavior and motivation pathways.
May influence neuroendocrine signaling in research models.
Targets MC4R and MC3R involved in central signaling.
Studied for its potential to modulate neurotransmitter systems.
Supports a wide range of neuroscience and behavioral research applications.
Technical Specifications
- Peptide
- PT-141 (Bremelanotide)
- Appearance
- White Lyophilized Powder
- Purity
- ≥99%
- Molecular Formula
- C50H68N14O10
- Molecular Weight
- ~1,025.2 g/mol
- Sequence
- XDHFRWK (Ac-Nle-Asp(1)-His-D-Phe-Arg-Trp-Lys(1)-OH)
- Storage (Lyophilized Powder)
- -20°C
- Storage After Reconstituted
- 2 °C TO 8°C
- Shelf Life
- 36 Months
- Grade
- Research Grade
- Application
- Laboratory Research
Quality Assurance
Manufactured under strict laboratory standards with purity verification and batch-controlled quality protocols.